AI & Machine Learning

onsemi will detail its long-term financial and innovation roadmap, focusing on capitalizing on AI, EV, and industrial megatrends amid fierce competition.

Following strong Q4 earnings, Datadog will detail its AI and cloud strategy at a major conference, with investors and tech leaders watching closely.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

LexisNexis integrates Anthropic's powerful Legal Plugin, escalating the AI arms race and promising a new era of automated, verifiable legal work.

Knights of Columbus Asset Advisors appoints fintech expert Deepak Devaraj to lead its $30B fund, signaling a new era for faith-based investing.

A Senate hearing highlights a growing national trend: using advanced tech to stop fraud and ensure billions in child care funds reach the families who need them.

A new national research initiative will explore how AI can help universities scale online programs without sacrificing quality, focusing on human-AI collaboration.

New research shows employees bypass learning platforms for managers. Go1's new tool empowers managers to fund real-world development beyond eLearning.

With $3M in new funding, Kris@Work is building an AI-native platform to replace fragmented sales tools and end the era of enterprise SaaS fatigue.

Nabsys's electronic genome mapping reveals how rogue genetic elements damage our DNA, opening new frontiers in understanding cancer and neurodegeneration.

A new survey shows 85% of Americans recognize the AdChoices icon, but critics question if the symbol offers true privacy in a shifting regulatory landscape.

A new solar-powered detection trailer offers a flexible, data-driven weapon against a rising tide of wrong-way crashes on America’s highways.

With $6.9M in total funding, the UMass spin-out is set to disrupt AR and AI markets with its durable, all-inorganic nano-imprinted optical components.

A newly identified blood biomarker for the drug masitinib could revolutionize how doctors treat ALS, progressive MS, and Alzheimer's disease.

Groundbreaking research shows AI's information diet is dangerously imbalanced, creating an unseen force that could manipulate public opinion and erode democracy.

Erickson Immigration Group promotes Katie McDermott, signaling a major push to navigate the complex UK and Ireland corporate immigration markets.

As the world looks to Milano Cortina 2026, discover the crucial support system from the Challenged Athletes Foundation that powers over half of Team USA.

A new security framework from Crittora aims to eliminate a core AI vulnerability, making autonomous agents enterprise-ready and setting a new trust standard.

With 1,000 employers on board, TIAA and Nuveen's lifetime income funds are bringing pension-like certainty back to the 401(k) for over 1 million workers.

A massive new study finds ECGs save young lives, questioning UK policy as 12 die weekly from hidden heart conditions. Is repeat screening the answer?